SCHEMBL22624887

SCHEMBL22624887

CC(C)CS(=O)(=O)c1nnc[nH]1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15618861 0.84 SCN5A (0.30) —
SCHEMBL1458878 0.80 KDM4E (0.33) —
SCHEMBL16186181 0.75 L3MBTL1 (0.31) —
SCHEMBL11959960 0.71 — —
SCHEMBL8070359 0.70 ALDH1A1 (0.34) —
SCHEMBL939745 0.67 — —
SCHEMBL11455703 0.67 — —
SCHEMBL12050713 0.67 — —
SCHEMBL24810085 0.67 ALDH1A1 (0.41) —
SCHEMBL22950993 0.67 ALDH1A1 (0.39) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11155525-B2 Azole derivatives as apelin receptor agonist Sanford Burnham Prebys Medical Discovery Institute (US) 2021-10-26 — — US disclosed
US-20200347022-A1 NOVEL AZOLE DERIVATIVES AS APELIN RECEPTOR AGONIST DAIICHI SANKYO COMPANY, LIMITED (JP) 2020-11-05 — — US disclosed
Send feedback